Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study focuses on patients with Hereditary Angioedema (HAE) to better understand how mental health affects overall well-being. Through a questionnaire, the investigators will assess the presence of suicidal thoughts, anxiety, and depression, as well as cardiovascular risk markers. By analyzing these factors together, the investigators aim to identify possible links between mental health and heart health in people with HAE. This research will help improve care strategies and highlight the importance of mental well-being in managing HAE.
This observational study focuses on patients with Hereditary Angioedema (HAE) to explore the impact of mental health on overall well-being. Through a questionnaire, the investigators aim to assess not only the presence but also the severity of suicidal thoughts, as well as symptoms of anxiety and depression. Additionally, the investigators will evaluate how these mental health factors relate to disease variables such as HAE control, disease activity, and quality of life.
Beyond mental health, the investigators also seek to understand its connection to cardiovascular risk factors. By measuring triglycerides, glucose levels, and body mass index (BMI), the investigators aim to explore whether patients with higher suicide risk also face increased heart health risks. This research will help improve patient care by emphasizing the importance of both mental and physical health in managing HAE. After identifying patients with high risk of suicide ideation the investigators will conduct a folow-up study after patients have received mental health interventions and how evaluate how treatment can determine better HAE outcomes. With these resuts the investigators expect to attract the attention of the international scientific community to increase early detection and effective solutions to prevent suicide.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HAE-SAFE 1 | Patients with a diagnosis of hereditary angioedema confirmed by decreased C1-INH levels and/or decreased C1-INH activity or genomic sequencing |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Presence of suicide ideation severity as assessed by the Suicidal Ideation Attributes Scale (SIDAS) | SIDAS measures five attributes of suicidal thoughts. Each attribute is scored on a 10-point scale, with total SIDAS scores ranging from 0 to 50. A score of 0= No ideation, 1-20= Low ideation, 21-50= High ideation . | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Number of participant with an increased triglyceride glucose-body mass (TyG-BMI) index | The TyG-BMI index will be obtained using the following formula: ln[TG (mg/dL) × FPG (mg/dL)/2] × BMI (kg/m^2), where TG represents for triglycerides and FBG represents for fasting blood glucose. | In the previous 12 weeks or up to 12 weeks after enrollment |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with a confirmed diagnosis of hereditary angioedema who are treated at specialized centers in Latin America
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ivan Cherrez, MD, MSc. | Contact | +593 999981769 | ivancherrez@gmail.com | |
| Gabriela Rodas, MD. | Contact | +593 969115353 | gaby.rodasv@hotmail.com |
Not provided
Not provided
Data will be made available upon reasonable request to the principal investigato
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D054179 | Angioedemas, Hereditary |
| D059020 | Suicidal Ideation |
| ID | Term |
|---|---|
| D000799 | Angioedema |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D000081208 | Hereditary Complement Deficiency Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Number of patients with uncontrolled disease as assessed by the Angioedema Control Test (AECT) | A cut-off value of 10 points is used to differentiate patients with poor controlled angioedema from those with well-controlled disease | Day 1 |
| Number of patients with severe disease as assessed by the Hereditary Angioedema Activity Score: HAE-AS | A total score of 12 points will be used as a cutoff for severe disease | Day 1 |
| Number of patients with anxiety or depression as assessed by the Hospital Anxiety and Depression Scale (HADS) | HADS is a fourteen-item scale with seven items each for anxiety and depression subscales. Scoring for each item ranges from zero to three. A subscale score >8 denotes anxiety or depression. | Day 1 |
| D000081207 | Primary Immunodeficiency Diseases |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D014581 | Urticaria |
| D017445 | Skin Diseases, Vascular |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D013405 | Suicide |
| D016728 | Self-Injurious Behavior |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |